Synapse Signs an Agreement with Pfizer in Oncology Precision Medicine

Synapse Signs an Agreement with Pfizer in Oncology Precision Medicine

Shots:

  • Pfizer and Synapse collaborate to advance the cancer outcomes research using real-world evidence and accelerate new cancer therapies for the improvement of patient’s health with an initial focus on molecular testing and therapy choices in precision oncology in the healthcare
  • The focus of the collaboration is to better understand the treatments for people living with cancer and develop evidence-based insights to improve cancer outcomes
  • Syapse’s insights platform, data sharing network and industrial partnerships bring leading healthcare innovators into a unified ecosystem providing access to personalized care regardless of location or income

Click here to­ read full press release/ article | Ref: Globe Newswire | Image: Chicago Tribune